Abivax SA
LSE:0RA9
Abivax SA
LSE:0RA9
Price:
70.15
EUR
4.7%
Market Closed
Market Cap:
€700.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Abivax SA
LSE:0RA9
|
FR |
|
D
|
Dexcom Inc
F:DC4
|
US |
|
I
|
Integra Lifesciences Holdings Corp
XMUN:IL3
|
US |
|
Douyu International Holdings Ltd
NASDAQ:DOYU
|
CN |
|
J
|
JTL Industries Ltd
BSE:534600
|
IN |
|
L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA
PAR:AI
|
FR |
Wall St Price Targets
0RA9 Price Targets Summary
Abivax SA
Abivax SA
Wall Street analysts forecast 0RA9 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 0RA9 is 132.98 EUR with a low forecast of 63.94 EUR and a high forecast of 179.36 EUR.
Lowest Forecast
Price Target
63.94
EUR
9% Downside
Average Forecast
Price Target
132.98
EUR
90% Upside
Highest Forecast
Price Target
179.36
EUR
156% Upside
Abivax SA Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0RA9's stock price target?
Price Target
132.98
EUR
132.98
EUR
According to Wall Street analysts, the average 1-year price target for 0RA9 is 132.98 EUR with a low forecast of 63.94 EUR and a high forecast of 179.36 EUR.
